8-epi-prostaglandin F2alpha

a potent preglomerular vasoconstrictor acting principally through thromboxane A2 receptor activation

Also Known As:

15-F(2t)-IsoP; 15-F(2t)-isoprostane; 15-F2t-IsoP; 15-F2t-isoprostane; 8-F(2t)-isoprostane; 8-epi-PGF2 alpha; 8-epi-PGF2alpha; 8-epiprostaglandin F2alpha; 8-iso-PGF(2alpha); 8-iso-PGF2alpha; 8-isoprostaglandin F2alpha; 8-isoprostane; isoprostaglandin F2alpha type-III; Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,8beta,9alpha,11alpha,13E,15S)-

Pharmalogical Action Categories:

D014662 - Vasoconstrictor Agents

Lipids: 118169
- Fatty Acids: 28212
  - Unsaturated Fatty Acids: 8458
    - Eicosanoids: 3282
      - Prostaglandins: 17184
        Prostaglandins F: 682
        Dinoprost: 1558
        8-epi-prostaglandin F2alpha: 611
Biological Factors: 2560
- Inflammation Mediators: 1126
  - Autacoids: 278
    - Eicosanoids: 3282
      - Prostaglandins: 17184
        Prostaglandins F: 682
        Dinoprost: 1558
        8-epi-prostaglandin F2alpha: 611

Anila Kumar Selected Research

Anila Kumar Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure